Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	New prostate cancer test cuts biopsies by 50% in US - 16 days ago Beckley Psytech announces positive results for ELE-101 in depression trial - about 1 month ago
2	Kristen Monaco MedPage Today	Imcivree Label Expanded; Weight Loss With Weekly Injection; Kidney Donation Chain - 28 days ago Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening - 4 months ago Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update - 5 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 6 months ago Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - 10 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 11 months ago Tirzepatide Wins FDA Approval for Weight Loss - about 1 year ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL - about 1 month ago Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP - about 2 months ago Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL - about 1 year ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - about 1 year ago
4	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - about 2 months ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more - 2 months ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - about 1 year ago STAT+: Pharmalittle: Eisai reports injectable version of Alzheimer’s drug as effective as IV; Pfizer says combo flu and Covid shot shows strong response - about 1 year ago STAT+: Teva sues Colorado over ‘unconstitutional’ program to lower cost of epinephrine injectors - over 1 year ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - over 1 year ago
6	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	New Framework for Deciding When to Operate on Patients With Epiretinal Membranes - 2 months ago IL-13 Blocker for Eczema Maintains Efficacy at Less-Frequent Dosing - about 1 year ago
7	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 3 months ago
8	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Lebrikizumab Wins FDA Approval for Eczema - 4 months ago
9	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative - 5 months ago With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and PBMs - 5 months ago Eli Lilly Drug Reduces Risk of Diabetes Onset, Building Case for Broader Use of the Therapy - 5 months ago
10	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Lilly has more positive data on its weekly insulin - 5 months ago

Journalists covering ePI